Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-01-16
2007-01-16
Tran, S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S424000, C424S425000, C424S451000, C424S454000
Reexamination Certificate
active
10173992
ABSTRACT:
An osmotic delivery system for controlled delivery of a beneficial agent includes an implantable capsule containing a beneficial agent and an osmotic engine that swells on contact with water, thereby causing the release of the beneficial agent over time. The osmotic delivery system has a membrane material that allows a controlled amount of fluid to enter from an exterior of the capsule, while preventing the compositions within the capsule from passing out of the capsule. The osmotic delivery system is designed to meet at least the operating pressures of 1000 psi. The membrane material is cast, calendered or extruded followed by machining (i.e., die-cutting, stamping or otherwise cutting to shape) to provide a uniform nonribbed membrane material. The capsule also includes a membrane material-retaining means that is positioned at a fluid uptake end to retain the membrane material within the capsule, even under periods of high pressure.
REFERENCES:
patent: 3732865 (1973-05-01), Higuchi et al.
patent: 3987790 (1976-10-01), Eckenhoff et al.
patent: 4865845 (1989-09-01), Eckenhoff et al.
patent: 5059423 (1991-10-01), Magruder et al.
patent: 5112614 (1992-05-01), Magruder et al.
patent: 5137727 (1992-08-01), Eckenhoff
patent: 5213809 (1993-05-01), Wright et al.
patent: 5234692 (1993-08-01), Magruder et al.
patent: 5234693 (1993-08-01), Magruder et al.
patent: 5308348 (1994-05-01), Balaban et al.
patent: 5413572 (1995-05-01), Wong et al.
patent: 5540665 (1996-07-01), Mercado et al.
patent: 5728396 (1998-03-01), Peery et al.
patent: 5985305 (1999-11-01), Peery et al.
patent: 5997527 (1999-12-01), Gumucio et al.
patent: 6113938 (2000-09-01), Chen et al.
patent: 6287295 (2001-09-01), Chen et al.
patent: 6544252 (2003-04-01), Theeuwes et al.
patent: 2003/0114837 (2003-06-01), Peterson et al.
patent: 2004/0097906 (2004-05-01), Fereira et al.
patent: 2004/0102762 (2004-05-01), Gilbert
patent: 2005/0101943 (2005-05-01), Ayer et al.
patent: 2005/0131389 (2005-06-01), Peterson et al.
patent: WO 99/33446 (1999-07-01), None
patent: WO 99/33446 (1999-07-01), None
Author unknown, “Engineer's Guide to Plastics,” Materials Engineering, Unknown, vol. 5 (No. 72), p. 38-45, (Jul. 17, 1972).
Kildsig, D.O. et al., “Theoretical Justification of Reciprocal . . . ,” Jrl. Pharma. Sciences, vol. 59 (No. 11), p. 1634-1637, (Nov. 17, 1970).
Rogers, C.E. et al., “Permeability Valves,” Ind. and Eng. Chem., vol. 49 (No. 11), p. 1933-1936, (Nov. 17, 1957).
Ann. Book of ASTM Stds., vol. 8.02, pp. 208-211 and pp. 584-587 (1984).
Morgan, P.W.., “Structure and Moisture Permeability . . . ,” Ind. Eng. Chem., vol. 45 (No. 10), pp. 2296-2306 (1953).
Brown James E.
Gilbert Scott J.
Peery John R.
ALZA Corporation
Tran S.
LandOfFree
Osmotic implant with membrane and membrane retention means does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osmotic implant with membrane and membrane retention means, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osmotic implant with membrane and membrane retention means will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3735593